By proceeding, you agree to our Terms of Use and Privacy Policy.
Is complexity something bad? We don’t think so. For us, complexity is just a fact of life. There is no point in simplifying something when you’re really just throwing away valuable information. The best thing we can do about complexity is to make it manageable. That is what we do with our database software. For over 20 years now, Stegmann Systems has been developing database software solutions (PLA & APS) for the regulated industry. Their software PLA supports the development, execution and analysis of biological assays and is used by over 700 pharmaceutical and biotech companies worldwide. Among them are the top 100 biotech companies together with laboratories, universities, research institutions and regulatory authorities.
02-02 October 2023
Many of the exciting advances in drug discovery and development today concern the immune response and its manipulation and control. Our understanding of immune involvement in therapeutic disorders and their treatment is developing rapidly. T and B ly
Event Ended
Hybrid
Paid
Washington, DC
02-05 October 2023
CHI is excited to host its 15th Annual Immunogenicity & Bioassay Summit in Washington, D.C. We’ll examine challenges facing the industry with NEW case studies, NEW perspectives and NEW approaches. Learn from the industry, academia and the regulatory
03-04 October 2023
This year's Immunogenicity Summit brings the FDA together with leading industry and academic experts to discuss the development, application and validation of immunogenicity assays. Learn how to manage drug and target interference and tolerance, unde